ClinicalTrials.gg
RecruitingNCT07542769CALM-PRUpdated May 26, 2026

Choice and Autonomy in Learning Mindfulness for Pediatric Residents

An interventional study of Wakeful Digital Mindfulness Program in Program Engagement, Treatment Adherence and Compliance and Mindfulness, sponsored by Northwestern University. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-05-26.

Sponsored by Northwestern University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.

Planned enrollment
46th of 70
42 · median 66
Started
2026
with 4 others
No phase
58 of 75
8 open now
Primary completion
2026-12
later than 3 of 14 live
Registered
70th of 75
by date

Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 46th largest by planned enrollment of the 70 interventional ones that give a count, is one of 5 that started in 2026, is one of 58 with no phase, reaches primary completion later than 3 of the 14 other live ones, and was the 70th registered.

Treatment Adherence and Compliance

353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.

Browse Treatment Adherence and Compliance studies →

Open to participants now

12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.

This study: all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Treatment Adherence and Compliance with a site in United States, or all of them as a file.
02

Study summary

This study is a pilot clinical trial designed to evaluate a flexible, online mindfulness program for pediatric residents. Medical training can be stressful, and although mindfulness programs are often offered to support well-being, many are either in-person or follow a fixed format that may not fit individual schedules or preferences. This study will test a digital mindfulness program called Wakeful, which allows participants to complete the course at their own pace. Participants will be randomly assigned to one of two groups: one group will be able to choose the length of their mindfulness program (3, 5, or 7 weeks), while the other group will be assigned a program length without a choice. The goal is to understand whether giving participants a choice improves how often they use the program, how satisfied they are with it, and whether they complete it. The main outcomes of this study focus on how participants interact with the program, including how many sessions they complete, how often they practice mindfulness on their own, and how useful and relevant they find the program. The study will also look at overall satisfaction and how many participants drop out before finishing. In addition, the study will explore whether participants report changes in mindfulness and compassion for others, although it is not designed to determine clinical improvements in mental health. By understanding how pediatric residents engage with different program formats, this study aims to inform the design of more flexible and user-centered digital wellness programs that better fit into demanding medical training environments.

Read the detailed description

This pilot randomized study evaluates the feasibility, acceptability, and user engagement of a digital, asynchronous mindfulness-based intervention (Wakeful) among pediatric residents. The study is designed to address a key limitation in existing mindfulness interventions: the predominance of "one-size-fits-all" program structures that may not align with the time constraints, preferences, and autonomy of medical trainees.

Background and Rationale

Pediatric residents experience significant occupational stress due to demanding clinical schedules, high patient volumes, and emotionally complex care environments. Although mindfulness-based interventions, including those derived from Mindfulness-Based Stress Reduction (MBSR), have demonstrated potential benefits, traditional in-person formats are often impractical for trainees. Digital mindfulness programs offer increased accessibility; however, engagement and adherence remain suboptimal.

A potential contributor to low engagement is the lack of personalization in program design. Most digital interventions prescribe a fixed duration and structure, without accounting for individual differences in time availability, motivation, or perceived burden. Allowing participants to choose key aspects of the intervention-such as program length-may enhance perceived autonomy and improve engagement and acceptability.

Study Objectives

The primary objective of this study is to evaluate whether offering participants a choice of intervention duration (3, 5, or 7 weeks) influences engagement, adherence, and acceptability of a digital mindfulness program.

Secondary exploratory objectives include assessing trends in self-reported mindfulness and compassion for others following participation in the program.

Study Design

This is a randomized, parallel-group pilot study conducted among pediatric residents at a single academic institution. Approximately 42 participants will be enrolled and randomized in a 1:1 ratio to one of two study arms:

Choice Arm (n = 21): Participants select their preferred program duration (3, 5, or 7 weeks).

No-Choice Arm (n = 21): Participants are assigned a program duration without input, using a matched randomization approach to ensure balanced distribution across durations.

Participants in both arms will complete one Wakeful session per week based on their assigned or selected schedule. Each session lasts approximately 45-60 minutes and includes didactic content, guided meditation, and optional reflective exercises.

Intervention

Wakeful is a web-based mindfulness program developed at Northwestern University. It delivers structured weekly content incorporating mindfulness principles, including attention awareness, emotional regulation, and loving-kindness practices. The platform includes guided meditations, educational materials, and optional community reflection features.

Participants may also engage in optional independent mindfulness practices outside of the structured sessions. All engagement occurs remotely, and participants may access the program via computer, tablet, or smartphone.

Data Collection and Outcome Measures Primary Outcomes (Engagement and Acceptability)

Primary outcomes focus on user interaction with the intervention and include:

Module completion rates Frequency and duration of platform use Independent meditation practice frequency Participant-reported usability and perceived relevance Satisfaction with the program Attrition and dropout rates

These measures will be derived from de-identified platform usage data and participant surveys.

Secondary (Exploratory) Outcomes

Exploratory outcomes include changes in:

Mindfulness (PROMIS Global Mindfulness Measure) Compassion for others (Neff Compassion Scale)

The study is not powered to detect statistically significant differences in psychological outcomes; these analyses are descriptive and hypothesis-generating.

Procedures

After providing informed consent, participants will be randomized to study arm. Those in the Choice Arm will select their preferred program duration, while those in the No-Choice Arm will be assigned a duration.

Participants will complete:

A baseline questionnaire prior to beginning the intervention A post-intervention questionnaire at program completion An optional in-person debrief interview 2-4 weeks after completion (subset of participants)

The debrief interviews will explore participant experiences, including factors influencing their engagement and perceptions of program structure.

Data Handling

All usage data collected by the Wakeful platform will be de-identified and linked only to a study ID. No personally identifiable information will be included in analytic datasets. Data will be stored on secure, encrypted servers, and only authorized study personnel will have access.

Significance

This study focuses on feasibility and user experience rather than clinical efficacy. By evaluating whether participant choice influences engagement, the findings will inform the design of future digital mindfulness interventions that prioritize flexibility, personalization, and alignment with the realities of medical training environments.

03

Conditions studied

  • Program Engagement
  • Treatment Adherence and Compliance
  • Mindfulness
  • Self-Compassion
  • Physician Burnout
  • Psychological Well-Being
  • Meditation
  • Meditation Training

Keywords

  • Mindfulness
  • Meditation
  • Digital Health Intervention
  • Internet-Based Intervention
  • Physician Well-Being
  • Graduate Medical Education
  • Pediatric Residency
  • Treatment Adherence and Compliance
  • Patient Acceptance of Health Care
  • Program Engagement
  • User Engagement
  • Pilot Projects
  • Self-Compassion
  • Compassion
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current categorical pediatrics residents at Northwestern University.
  • Preliminary pediatrics residents who intend to continue in pediatrics.
  • Willing and able to provide .

Exclusion criteria

Exclusion Criteria:

- None; all pediatric residents meeting inclusion criteria are eligible.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Choice

    Participants randomized to the Choice arm will select their preferred duration of the Wakeful digital mindfulness program (3, 5, or 7 weeks) prior to beginning the intervention. After making their selection, participants will complete one module per week in sequential order based on their chosen program length. Each module includes didactic content, guided mindfulness practices, and optional reflection activities. Participants may also engage in optional independent meditation practices throughout the study period. This arm is designed to evaluate whether allowing participants to choose their intervention duration influences engagement, adherence, and acceptability of the program.

    Behavioral: Wakeful Digital Mindfulness Program

  • Experimental
    No Choice

    Participants randomized to the No-Choice arm are assigned a Wakeful digital mindfulness program duration (3, 5, or 7 weeks) without input. Assignment is matched to participants in the Choice arm to balance program lengths across groups. Participants complete one module per week in sequential order according to their assigned program length. Each module includes didactic content, guided mindfulness practices, and optional reflection activities. Optional independent meditation practice is also available. This arm is designed to assess engagement, adherence, and acceptability under a structured format without participant-selected program duration.

    Behavioral: Wakeful Digital Mindfulness Program

Interventions

  • BehavioralWakeful Digital Mindfulness Program

    Wakeful digital mindfulness program: an asynchronous, web-based course with guided meditations, didactic content, and optional reflective exercises.

06

What researchers measure

Primary outcomes

  1. Engagement and completion of Wakeful program modules

    The primary outcome measures participant engagement with the Wakeful digital mindfulness program, including (1) the number of program modules completed, (2) frequency and duration of platform use, (3) frequency of independent meditation practice, (4) perceived usability and relevance, and (5) overall satisfaction and dropout rates. All measures are collected via de-identified platform usage data and post-intervention surveys to assess acceptability and adherence.

    Time frame: Baseline and immediately post-intervention (3, 5, or 7 weeks depending on program length)

Secondary outcomes

  1. Changes in mindfulness, self-compassion, and compassion for others

    Exploratory outcomes assess trends in psychological constructs following the Wakeful digital mindfulness program. Measures include mindfulness using the PROMIS Global Mindfulness Measure, self-compassion using the Neff Self-Compassion Scale, and compassion for others using the Neff Compassion Scale. These surveys are completed at baseline and post-intervention. The study is not powered for statistical comparisons; analyses are descriptive to guide future intervention design.

    Time frame: Baseline and immediately post-intervention (3, 5, or 7 weeks depending on program length)

07

Study locations

1 of 1 sites recruiting
  • McGaw Medical Center
    Chicago, Illinois 60622, United States
    Recruiting
08

References and documents

Publications

  • Lebares CC, Hershberger AO, Guvva EV, Desai A, Mitchell J, Shen W, Reilly LM, Delucchi KL, O'Sullivan PS, Ascher NL, Harris HW. Feasibility of Formal Mindfulness-Based Stress-Resilience Training Among Surgery Interns: A Randomized Clinical Trial. JAMA Surg. 2018 Oct 1;153(10):e182734. doi: 10.1001/jamasurg.2018.2734. Epub 2018 Oct 17. PubMed 30167655 ↗
  • Brun C, Akinyemi A, Houtin L, Mizzi C, Cardoso T, Isnard Bagnis C. Mindfulness and compassion training for health professionals: A qualitative study. Front Psychol. 2023 Jan 12;13:1113453. doi: 10.3389/fpsyg.2022.1113453. eCollection 2022. PubMed 36710842 ↗
  • Fendel JC, Aeschbach VM, Schmidt S, Goritz AS. The impact of a tailored mindfulness-based program for resident physicians on distress and the quality of care: A randomised controlled trial. J Intern Med. 2021 Dec;290(6):1233-1248. doi: 10.1111/joim.13374. Epub 2021 Sep 23. PubMed 34369618 ↗
  • Verweij H, van Ravesteijn H, van Hooff MLM, Lagro-Janssen ALM, Speckens AEM. Does Mindfulness Training Enhance the Professional Development of Residents? A Qualitative Study. Acad Med. 2018 Sep;93(9):1335-1340. doi: 10.1097/ACM.0000000000002260. PubMed 29697426 ↗
  • Watts KJ, O'Connor M, Johnson CE, Breen LJ, Kane RT, Choules K, Doyle C, Buchanan G, Yuen K. Mindfulness-Based Compassion Training for Health Professionals Providing End-of-Life Care: Impact, Feasibility, and Acceptability. J Palliat Med. 2021 Sep;24(9):1364-1374. doi: 10.1089/jpm.2020.0358. Epub 2021 Mar 5. PubMed 33666500 ↗
  • Rojas B, Catalan E, Diez G, Roca P. A compassion-based program to reduce psychological distress in medical students: A pilot randomized clinical trial. PLoS One. 2023 Jun 23;18(6):e0287388. doi: 10.1371/journal.pone.0287388. eCollection 2023. PubMed 37352295 ↗
  • Victorson D, Morone NE, Pilkonis PA, Schalet B, Yu L, Jackson KL, Dodds N, Horowitz B, Johnston K, McFarland C, Klem ML, Sauer C, Choi S, Moskowitz JT, Ong JC, Addington EL, Satyshur MD, Suss SJ, Daehler S, Greco CM. Using PROMIS Methodology to Create Self-Report Measures of Mindfulness and Related Concepts. Glob Adv Integr Med Health. 2024 Oct 3;13:27536130241290771. doi: 10.1177/27536130241290771. eCollection 2024 Jan-Dec. PubMed 39381495 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.

Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 14, 2026
First posted
Apr 21, 2026
StartActual
Apr 13, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
May 1, 2027
Last update
May 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07542769
Responsible party
Jason Tsichlis (Pediatric Hospital Medicine Fellow, Northwestern University) — Principal investigator
First posted
Apr 21, 2026
Start date
Apr 13, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
May 1, 2027 (estimated)
Last update
May 26, 2026

Study contacts

Jason T Tsichlis, MD, MS
Contact
jtsichlis@luriechildrens.org
312-227-4000
Gabrielle Osher
Contact
gabrielle.osher@northwestern.edu
312-227-4000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion